4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0000899243-21-017187
Director disposed of 504,084 shares (other)
- Director acquired 20,331 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woiwode Thomas Director | 2021-04-26 | Other disposition | −485,979 | 1,943,916 | I | ||
| Woiwode Thomas Director | 2021-04-26 | Other acquisition | +9,720 | 9,720 | I | ||
| Woiwode Thomas Director | 2021-04-26 | Other disposition | −9,720 | 0 | I | ||
| Woiwode Thomas Director | 2021-04-26 | Other acquisition | +8,385 | 8,385 | I | ||
| Woiwode Thomas Director | 2021-04-26 | Other disposition | −8,385 | 0 | I | ||
| Woiwode Thomas Director | 2021-04-26 | Other acquisition | +2,226 | 2,226 | D |
Loading xslF345X03/doc4.xml…